LON:WELL Holdings Information

LON:WELL is an equity ETF with a total of 45 individual holdings. The top holdings are Eli Lilly and Company stock at 9.03%, Ascendis Pharma at 8.87%, Natera at 5.99%, Rhythm Pharmaceuticals at 4.61%, and Cash at 4.54%.

Total Holdings

Top 10 Percentage

50.80%

Asset Class

Equity

ETF Category

Health Care

Assets

12.07M

PE Ratio

25.69

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	9.03%	1,262
2	ASND	Ascendis Pharma A/S	8.87%	6,040
3	NTRA	Natera, Inc.	5.99%	2,614
4	RYTM	Rhythm Pharmaceuticals, Inc.	4.61%	7,600
5	n/a	Cash	4.54%	2,694,195
6	INSM	Insmed Incorporated	3.74%	5,017
7	ARGX	argenx SE	3.70%	602
8	RVMD	Revolution Medicines, Inc.	3.58%	3,022
9	ABBV	AbbVie Inc.	3.40%	2,074
10	PCVX	Vaxcyte, Inc.	3.33%	9,236
11	GH	Guardant Health, Inc.	3.08%	2,766
12	GILD	Gilead Sciences, Inc.	2.91%	3,109
13	UNH	UnitedHealth Group Incorporated	2.87%	1,219
14	DHR	Danaher Corporation	2.37%	1,802
15	ABVX	ABIVAX Société Anonyme	2.32%	3,556
16	PODD	Insulet Corporation	2.25%	2,574
17	COR	Cencora, Inc.	2.18%	1,139
18	MCK	McKesson Corporation	2.04%	375
19	IDXX	IDEXX Laboratories, Inc.	1.99%	626
20	MRK	Merck & Co., Inc.	1.82%	1,986
21	UTHR	United Therapeutics Corporation	1.77%	577
22	VRTX	Vertex Pharmaceuticals Incorporated	1.70%	540
23	MDGL	Madrigal Pharmaceuticals, Inc.	1.61%	488
24	DXCM	DexCom, Inc.	1.60%	2,882
25	HQY	HealthEquity, Inc.	1.60%	2,703

Showing 25 of 45 holdings

Subscribe to see the full list

Activate Now

As of Sep 21, 2026